Development of rapid guidelines: 2. A qualitative study with WHO guideline developers

Health Research Policy and Systems
Ivan D FlorezHolger J Schünemann

Abstract

Situations such as public health emergencies and outbreaks necessitate the development and publication of high-quality recommendations within a condensed timeframe. For example, WHO has produced examples of and guidance for the development of rapid guidelines (RGs). However, more information is needed to understand the experiences and perceptions of guideline developers. This is the second of a series of three articles addressing methodological issues around RGs. This study describes the perceptions and experiences of guideline developers at WHO about RGs. We conducted interviews consisting of open- and closed-ended questions with guideline developers at WHO. Our analysis described the definition and rationale of RGs, the differences from regular guidelines with regard to timelines from topic definition until publication, barriers to identifying the evidence and the lack of a standard methodology to develop RGs. We interviewed 10 participants, the majority of whom were comfortable with the current WHO definition of RGs. Most stated that the rationale for developing RGs should be in response to new evidence about efficacy, cost-effectiveness or safety. Respondents differed with regards to the amount of time RGs should take. Whil...Continue Reading

References

Aug 10, 2000·International Journal of Technology Assessment in Health Care·D HaileyW Schneider
Aug 15, 2000·Research in Nursing & Health·M Sandelowski
Dec 5, 2006·Health Research Policy and Systems·Atle FretheimAndrew D Oxman
May 12, 2007·Lancet·Andrew D OxmanAtle Fretheim
Apr 11, 2008·International Journal of Technology Assessment in Health Care·Amber WattGuy Maddern
Sep 10, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Tsogzolmaa DorjgochooJean W Pape
Dec 17, 2009·Research in Nursing & Health·Margarete Sandelowski
Jul 7, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Melissa C BrouwersUNKNOWN AGREE Next Steps Consortium
Jul 21, 2010·Implementation Science : IS·Rebecca GanannHelen Thomas
Mar 22, 2012·The Canadian Journal of Cardiology·Allan C SkanesUNKNOWN Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee
Apr 20, 2012·Artificial Organs·Ioannis GriveasMichael World
May 17, 2012·Systematic Reviews·Sara KhanguraDavid Moher
Dec 18, 2013·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Holger J SchünemannElie A Akl
Jul 1, 2014·Academic Medicine : Journal of the Association of American Medical Colleges·Bridget C O'BrienDavid A Cook
Jan 16, 2015·Systematic Reviews·Holger J Schünemann, Lorenzo Moja
Apr 30, 2016·Environment International·Kristina A Thayer, Holger J Schünemann

❮ Previous
Next ❯

Citations

Jul 15, 2018·Health Research Policy and Systems·Rebecca L MorganHolger J Schünemann
Jun 30, 2018·Health Research Policy and Systems·Tikki Pang, Gianna Gayle Herrera Amul
Jul 15, 2018·Health Research Policy and Systems·Sergio C KowalskiHolger J Schünemann
Oct 4, 2020·Journal of Clinical Epidemiology·Elie A AklHolger Schünemann

❮ Previous
Next ❯

Software Mentioned

Appraisal of Guidelines for Research & Evaluation Instrument (...

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.